Joel Greenblatt's position in Biomarin Pharmaceutical - Registered Shares is currently worth $702 Thousand. That's 0.01% of their equity portfolio (950th largest holding). The first Biomarin Pharmaceutical - Registered Shares trade was made in Q3 2014. Since then Joel Greenblatt bought shares nine more times and sold shares on eleven occasions. The investor's estimated purchase price is $982 Thousand, resulting in a loss of 29%.